DOCSLIB.ORG

List of Entries

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Entries List of Entries Essays are shown in bold A Afferent Fibers (Neurons) Acid-Sensing Ion Channels AFibers(A-Fibers) NICOLAS VOILLEY,MICHEL LAZDUNSKI A Beta(β) Afferent Fibers Acinar Cell Injury A Delta(δ) Afferent Fibers (Axons) Acrylamide A Delta(δ)-Mechanoheat Receptor Acting-Out A Delta(δ)-Mechanoreceptor Action AAV Action Potential Abacterial Meningitis Action Potential Conduction of C-Fibres Abdominal Skin Reflex Action Potential in Different Nociceptor Populations Abduction Actiq® Aberrant Drug-Related Behaviors ® Ablation Activa Abnormal Illness Affirming States Activation Threshold Abnormal Illness Behavior Activation/Reassurance GEOFFREY HARDING Abnormal Illness Behaviour of the Unconsciously Motivated, Somatically Focussed Type Active Abnormal Temporal Summation Active Inhibition Abnormal Ureteric Peristalsis in Stone Rats Active Locus Abscess Active Myofascial Trigger Point Absolute Detection Threshold Activities of Daily Living Absorption Activity ACC Activity Limitations Accelerated Recovery Programs Activity Measurement Acceleration-Deceleration Injury Activity Mobilization Accelerometer Activity-Dependent Plasticity Accommodation (of a Nerve Fiber) Acupuncture Acculturation Acupuncture Efficacy EDZARD ERNST Accuracy and Reliability of Memory Acupuncture Mechanisms β ACE-Inhibitors, Beta( )-Blockers CHRISTER P.O. C ARLSSON Acetaminophen Acupuncture-Like TENS Acetylation Acute Backache Acetylcholine Acute Experimental Monoarthritis Acetylcholine Receptors Acute Experimental Synovitis Ach, ACh Acute Inflammatory Demyelinating Acidosis Polyneuropathy 2682 List of Entries Acute Ischemia Test Adjuvant Analgesics in Management of Acute Knee Joint Inflammation Cancer-Rated Bone Pain KERI L. FAKATA,ARTHUR G. LIPMAN Acute Lumbago Adjuvant Analgesics in Management of Acute Pain Cancer-Related Neuropathic Pain ROSS MACPHERSON,MICHAEL J. COUSINS DAV I D LUSSIER,RUSSELL K. PORTENOY Acute Pain in Children, Post-Operative Adjuvant Arthritis JOLENE D. BEAN-LIJEWSKI ADLs Acute Pain in Children, Procedural Adrenergic Agonist CHRISTINA LIOSSI Adrenergic Antagonist Acute Pain Management in Infants Adrenoceptors REBECCA PILLAI RIDDELL,BONNIE J. STEVENS Acute Pain Mechanisms Adult Respiratory Distress Syndrome PAUL M. MURPHY Adverse Effects Acute Pain Service Adverse Neural Tension Acute Pain Team Adverse Selection Acute Pain, Subacute Pain and Chronic Pain Aerobic Exercise WADE KING Affective Acute Painful Diabetic Neuropathy Affective Analgesia Acute Pelvic Pain Affective Component (Aspekt, Dimension) of Pain Acute Phase Protein Affective Responses Acute Post-Operative Pain in Children Affective-Motivational Acute Postoperative Pain Therapy Affective-Motivational Dimension of Pain Acute Procedural Pain in Children Afferent Fiber / Afferent Neuron Acute Salpingitis Afferent Projections Acute Sciatica Afferent Signal Acute Stress Disorder Afterdischarge(s) Afterhyperpolarisation Acute-Recurrent Pain After-Pains, Postnatal Pain Adaptation Age and Chronicity Adaptation Phase Age Regression Adaptive Equipment Age-Related Pain Diagnoses ADD Protocol Aggression Addiction Agonist Adduction Agreed Medical Examination Adenoassociated Virus Vectors AHP Adenoma AIDS and Pain Adenomyosis Alcock’s Canal Adenosine 5’ Triphosphate Alcohol-Induced Pancreatitis Adenoviral Vectors Alcoholism Adequate Stimulus Alfentanil Adherence Algesia Adhesion Molecules Algesic Agent / Algesic Chemical Adjunctive Drugs Algodystrohy Adjusted Odds Ratio Algogen Adjustment Disorder Algogenic Actions of Protons Adjuvant Algometer Adjuvant Analgesic Alice-in-Wonderland Syndrome List of Entries 2683 ALIF Amphibian Peptides Allele Dosage Study Amphipathic Alleles Amygdala Allocortex Amygdala, Functional Imaging Allodynia UTE HABEL,FRANK SCHNEIDER Allodynia (Clinical, Experimental) Amygdala, Nociceptive Processing ROLF-DETLEF TREEDE Amygdala, Pain Processing and Behavior in Allodynia and Alloknesis Animals ROBERT H. LAMOTTE BARTON H. MANNING Allodynia in Fibromyalgia Amygdaloid Complex Allodynia Test, Mechanical and Cold Allodynia Anaerobic Glycolysis KYUNGSOON CHUNG Analgesia Alloknesis Analgesia During Labor and Delivery Alloknesis and Allodynia YAAKOV BEILIN Allostasis Analgesia for Labor and Delivery Alpha(α) 1-Adrenergic Receptor Analgesic Effect of Oxycodone Alpha(α) 2-Adrenergic Agonist Analgesic Gap Alpha(α) 2-Adrenergic Receptor Agonists Analgesic Guidelines for Infants and Children STEPHEN C. BROWN Alpha(α) 2-Adrenoceptor Agonists Analgesic Ladder Alpha(α) 2-Adrenoceptors Analgesic Tolerance Alpha(α) 2-Adrenergic Agonists in Pain Treatment Analgesic Treatment CARSTEN BANTEL,MERVYN MAZE,LAURA Analgesics STONE,GEORGE WILCOX Analgesics, History α Alpha( ) 2-Agonists Analysis of Pain Behavior α Alpha( )-Adrenoceptors Anaphylactic Reaction α δ Alpha( )-Delta( ) Sleep Anaphylaxis α Alpha( )-D Galactose Anesthesia α Alpha( ) EEG Wave Intrusion Anesthesia Dolorosa α Alpha( )-I-Acid Glycoprotein Anesthesia Dolorosa Due to Plexus Avulsion AL-TENS Anesthesia Dolorosa Model, Autotomy Alternative Medicine MARSHALL DEVOR Alternative Medicine in Neuropathic Pain Anesthesiological Interventions MILES J. BELGRADE Anesthesiologist Alternative Rat Models of Ureteric Nociceptive Anesthetic Block Stimulation In Vivo Anesthetic Blockade Alternative Therapies Aneurysm Ambiguity Anger and Pain Amelioration AKIKO OKIFUJI Amenorrhea Anger-In American Society of Anesthesiologists’ Status Angiitis of the CNS Category Amide Anesthetic Angina Pectoris Amide Local Anesthetic Angina Pectoris, Neurophysiology and Psychophysics Aminobisphosphonate STAN ANDERSON,SHINJI OHARA,NIRIT Aminomethyl-Cyclohexane-Acetic Acid WEISS,FRED A. LENZ Amitriptyline Angiogenesis AMPA Glutamate Receptor (AMPA Receptor) Angiography 2684 List of Entries Animal Models and Experimental Tests to Study Apoptosis Nociception and Pain Apoptotic Degeneration JIN MO CHUNG Appraisal Animal Models for Mononeuropathy APS Animal Models of Inflammatory Bowel Disease APT JULIE A. CHRISTIANSON,BRIAN DAV I S Arachadonic Acid Animal Models of Inflammatory Muscle Pain Arachnoid Membrane Animal Models of Inflammatory Myalgia Archispinothalamic Tract Ankylosing Spondylitis ARDS Ankylosis Area Postrema Annulus Fibrosus Area under the Curve Anorexia Arousal Antecedents and Consequences of Behaviour Arterial Spasm Anterior Cingulate Cortex Arthralgias Anterior Lumbar Interbody Fusion Arthritis Anterior Primary Ramus Arthritis Model, Adjuvant-Induced Arthritis Anterior Pulvinar Nucleus LUCY F. DONALDSON,NAOMI L. Anterior Spinothalamic Tract CHILLINGWORTH Anterograde Axonal Tracer (Anterograde Labeling) Arthritis Model, Kaolin-Carrageenan Induced Arthritis (Knee) Anterograde Transport VOLKER NEUGEBAUER Anterolateral Cordotomy Arthritis Model, Osteoarthritis Antiarrythmics JAMES D. POMONIS Anticholinergics Arthritis Urethritica Anticipatory Anxiety Arthritogenic Pain Anticonvulsant (Agent) Articular Antidepressant Analgesics in Pain Management Articular Afferents, Morphology PETER N. WATSON,HAROLD MERSKEY KARL MESSLINGER Antidepressant Drugs Articular Nociceptors Antidepressants in Neuropathic Pain HANS-GEORG SCHAIBLE SØREN H. SINDRUP,TROELS S. JENSEN Articular Nociceptors, Sensitization Antidromic Activation/Invasion Articular Sensory Receptors Antidromic Microstimulation Mapping As Needed Dosage Regimen Antiepileptic Drugs (Agents) Ascending Nociceptive Pathways GLENN J. GIESLER JR Antihyperalgesic Effect Aseptic Meningitis Anti-Inflammatories ASICs Anti-Inflammatory Cytokines ASO Antinociception Aspartate Antinociceptive Effects of General Anesthetics Aspirin-Like Drugs Antinociceptive Models Assessment Antiphospholipid Syndrome Assessment of Discomfort in Dementia Protocol Antipyretic Analgesics Assessment of Hypoalgesia Antisense Oligonucleotide Assessment of Pain Behaviors Anxiety FRANCIS J. KEEFE,REBECCA W. PRYOR Anxiety Sensitivity Assimilation Anxiolysis Association Study Apamin Astrocytes Apoplexy Asymmetric Junctions List of Entries 2685 Ataxia Awakening Atenolol Awareness At-Level Neuropathic Pain Axillary Block At-Level Phenomena Axolemma ATP Axon ATP-Dependent Na+K+ Pump Axon Reflex ATrP Axonal Arborization Attachment Trigger Point Axonal Degeneration Attentional Bias Axonal Sprouting Attentional Mechanisms Axonal/Axoplasmic Transport Attributable Effect Axotomy Attributable Effect and Number Needed to Treat Azathioprine NIKOLAI BOGDUK Back Pain Atypical Antidepressants Back Pain in the Workplace Atypical Facial Neuralgia JOHN D. LOESER Atypical Facial Pain, Etiology, Pathogenesis and Back Schools Management Background Activity / Firing YAIR SHARAV Background Infusion Atypical Odontalgia Baclofen YAIR SHARAV Bad Back Atypical Trigeminal Neuralgia Balanced Analgesia AUC Balanced Analgesic Regime Audit Report Balneotherapy Aura Baricity Autacoids Barotraumas Autobiographical Memory Barreloids Autogenic Feedback Basal Ganglia Autogenic Training Basal Lamina Autologous Graft Basal Ventral Medial Nuclei Autologous Thrombocyte Injection as a Model Baseline Phase of Cutaneous Pain Basic Body Awareness Therapy JAMES A. BLUNK,MARTIN SCHMELZ Basic Work Activities Autonomic Basilar-Type Migraine Autonomic Dominant Cramping Disease Bcl–2 Autonomic Dysreflexia BDNF Autonomic Features
Load more

Recommended publications
  • The Creation of Neuroscience
    The Creation of Neuroscience The Society for Neuroscience and the Quest for Disciplinary Unity 1969-1995 Introduction rom the molecular biology of a single neuron to the breathtakingly complex circuitry of the entire human nervous system, our understanding of the brain and how it works has undergone radical F changes over the past century. These advances have brought us tantalizingly closer to genu- inely mechanistic and scientifically rigorous explanations of how the brain’s roughly 100 billion neurons, interacting through trillions of synaptic connections, function both as single units and as larger ensem- bles. The professional field of neuroscience, in keeping pace with these important scientific develop- ments, has dramatically reshaped the organization of biological sciences across the globe over the last 50 years. Much like physics during its dominant era in the 1950s and 1960s, neuroscience has become the leading scientific discipline with regard to funding, numbers of scientists, and numbers of trainees. Furthermore, neuroscience as fact, explanation, and myth has just as dramatically redrawn our cultural landscape and redefined how Western popular culture understands who we are as individuals. In the 1950s, especially in the United States, Freud and his successors stood at the center of all cultural expla- nations for psychological suffering. In the new millennium, we perceive such suffering as erupting no longer from a repressed unconscious but, instead, from a pathophysiology rooted in and caused by brain abnormalities and dysfunctions. Indeed, the normal as well as the pathological have become thoroughly neurobiological in the last several decades. In the process, entirely new vistas have opened up in fields ranging from neuroeconomics and neurophilosophy to consumer products, as exemplified by an entire line of soft drinks advertised as offering “neuro” benefits.
    [Show full text]
  • Activation of Orexin System Facilitates Anesthesia Emergence and Pain Control
    Activation of orexin system facilitates anesthesia emergence and pain control Wei Zhoua,1, Kevin Cheunga, Steven Kyua, Lynn Wangb, Zhonghui Guana, Philip A. Kuriena, Philip E. Bicklera, and Lily Y. Janb,c,1 aDepartment of Anesthesia and Perioperative Care, University of California, San Francisco, CA 94143; bDepartment of Physiology, University of California, San Francisco, CA 94158; and cHoward Hughes Medical Institute, University of California, San Francisco, CA 94158 Contributed by Lily Y. Jan, September 10, 2018 (sent for review May 22, 2018; reviewed by Joseph F. Cotten, Beverley A. Orser, Ken Solt, and Jun-Ming Zhang) Orexin (also known as hypocretin) neurons in the hypothalamus Orexin neurons may play a role in the process of general an- play an essential role in sleep–wake control, feeding, reward, and esthesia, especially during the recovery phase and the transition energy homeostasis. The likelihood of anesthesia and sleep shar- to wakefulness. With intracerebroventricular (ICV) injection or ing common pathways notwithstanding, it is important to under- direct microinjection of orexin into certain brain regions, pre- stand the processes underlying emergence from anesthesia. In this vious studies have shown that local infusion of orexin can shorten study, we investigated the role of the orexin system in anesthe- the emergence time from i.v. or inhalational anesthesia (19–23). sia emergence, by specifically activating orexin neurons utilizing In addition, the orexin system is involved in regulating upper the designer receptors exclusively activated by designer drugs airway patency, autonomic tone, and gastroenteric motility (24). (DREADD) chemogenetic approach. With injection of adeno- Orexin-deficient animals show attenuated hypercapnia-induced associated virus into the orexin-Cre transgenic mouse brain, we ventilator response and frequent sleep apnea (25).
    [Show full text]
  • Biocompatibility and Pharmacological Effects of Innovative Systems for Prolonged Drug Release Containing Dexketoprofen in Rats
    polymers Article Biocompatibility and Pharmacological Effects of Innovative Systems for Prolonged Drug Release Containing Dexketoprofen in Rats Liliana Mititelu-Tartau 1,†, Maria Bogdan 2,* , Daniela Angelica Pricop 3,*, Beatrice Rozalina Buca 1,†, Loredana Hilitanu 1,†, Ana-Maria Pauna 1,†, Lorena Anda Dijmarescu 4,† and Eliza Gratiela Popa 5 1 Department of Pharmacology, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania; liliana.tartau@umfiasi.ro (L.M.-T.);beatrice-rozalina.buca@umfiasi.ro (B.R.B.); [email protected] (L.H.); ana-maria-raluca-d-pauna@umfiasi.ro (A.-M.P.) 2 Department of Pharmacology, Faculty of Pharmacy, University of Medicine and Pharmacy, 200349 Craiova, Romania 3 Department of Physics, Faculty of Physics, “Al. I. Cuza” University, 700506 Iasi, Romania 4 Department of Obstetrics-Gynecology, Faculty of Medicine, University of Medicine and Pharmacy, 200349 Craiova, Romania; [email protected] 5 Department of Pharmaceutical Technology, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania; eliza.popa@umfiasi.ro * Correspondence: [email protected] (M.B.); [email protected] (D.A.P.) † These authors contributed equally to the study. Citation: Mititelu-Tartau, L.; Bogdan, Abstract: The present study reports on the in vivo biocompatibility investigation and evaluation of M.; Pricop, D.A.; Buca, B.R.; Hilitanu, the effects of liposomes containing dexketoprofen in somatic sensitivity in rats. Method: The lipo- L.; Pauna, A.-M.; Dijmarescu, L.A.; somes were prepared by entrapping dexketoprofen in vesicular systems stabilized with chitosan. The Popa, E.G. Biocompatibility and in vivo biocompatibility was evaluated after oral administration in white Wistar rats: Group I (DW): Pharmacological Effects of Innovative distilled water 0.3 mL/100 g body weight; Group II (DEX): dexketoprofen 10 mg/kg body weight Systems for Prolonged Drug Release (kbw); Group III (nano-DEX): liposomes containing dexketoprofen 10 mg/kbw.
    [Show full text]
  • Quercetin Attenuates Thermal Hyperalgesia and Cold Allodynia in STZ-Induced Diabetic Rats
    Indian Journal of Experimental Biology Vol. 42, August 2004, pp. 766-769 Quercetin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats Muragundla Anjaneyulu & Kanwaljit Chopra* Pharmacology Division, Universit y In stitute of Pharmaceutical Sciences, Panjab University, Chandigarh , I 60 014, India Received 21 January 2004; revised 5 May 2004 Neuropathic pain is one of the important mi crovascular complications of diabetes. Oxidative stress and superoxide play a criti cal role in th e development of neurovascular complications in diabetes. Aim of th e present study was to eva lu ate the effec t of qu ercetin, a bi onavo noid on thermal nocicepti ve responses in streptozotoci n (STZ)-induced diabetic rats assessed by tail-immersion and hot plate meth ods. After 4-weeks of a single intra venous STZ injecti on (45 mg/kg body wei ght), diabetic rat s exhibited a significant th ermal hyperal gesia and cold all odynia along with in creased plasma glucose and decreased body weights as compared with control rat s. Chronic treatment with quercetin (I 0 mg/kg body wei ght; p.o) for 4- weeks starting from the 4' 11 week of STZ-injection significantly attenuated th e cold all odyni a as well as hypera lges ia. Results indicate th at qu ercetin, a natural anti ox idant, may be helpful in diabetic neuropathy. Keywords: Diabeti c neuropathy, Hyperalgesia, Quercetin, Cold all odyni a, Tail-immersion, Hot plate. Neuropathic pain is one of the most common Based on analgesic and antioxidant properties of complications in diabetes mellitus.
    [Show full text]
  • Effect of Restraint Stress on Nociceptive Responses in Rats: Role of the Histaminergic System
    Niger. J. Physiol. Sci. 26(December 2011) 139 – 141 www.njps.com.ng Short communication Effect of restraint stress on nociceptive responses in rats: role of the histaminergic system *Ibironke G F and Mordi N E Department of Physiology, College of Medicine, University of Ibadan,Ibadan, Nigeria. Summary: Stress induced analgesia (SIA) is well known, but the reverse phenomenon, hyperalgesia is poorly documented. This study investigated the role of the histaminergic system in restraint stress hyperalgesia in rats, using thermal stimulation method (hot plate and tail flick tests). Paw licking and tail withdrawal latencies were taken before and after restraint for about one hour. Significant decreases (p< 0.05) were obtained in these latencies after the restraint in both tests. Administration of H1 and H2 receptor blockers, chlorpheniramine and cimetidine respectively 30 mins before the restraint still resulted in significant (p<0.05) reductions in these latencies, connoting the persistence of hyperalgesia, showing that histamine H1 and H2 receptors did not participate in the mechanism of restraint stress hyperalgesia. We therefore suggest a histaminergic independent mechanism for restraint stress induced hyperalgesia. Keywords: Restraint stress, Thermal stimulation, Hyperalgesia, Histamine. ©Physiological Society of Nigeria *Address for correspondence: [email protected] Manuscript Accepted: July, 2011 INTRODUCTION higher levels of suffering during stressful episodes (Conrad et al, 2007, Fishbain et al, 2006). Numerous Stress can have bilateral effects on pain related pre-clinical models have been developed to reproduce phenomena. Firstly, acute stress can produce various pain modalities that are encountered in the analgesia in humans and animals (Amit and Galina, clinic, however, animal studies assessing the 1986).
    [Show full text]
  • Differential Control of Opioid Antinociception to Thermal Stimuli in a Knock-In Mouse Expressing Regulator of ␣ G-Protein Signaling-Insensitive G O Protein
    The Journal of Neuroscience, March 6, 2013 • 33(10):4369–4377 • 4369 Cellular/Molecular Differential Control of Opioid Antinociception to Thermal Stimuli in a Knock-In Mouse Expressing Regulator of ␣ G-Protein Signaling-Insensitive G o Protein Jennifer T. Lamberts,1 Chelsea E. Smith,1 Ming-Hua Li,3 Susan L. Ingram,3 Richard R. Neubig,1,2 and John R. Traynor1 1Department of Pharmacology, and 2Center for the Discovery of New Medicines, University of Michigan Medical School, Ann Arbor, Michigan 48109, and 3Department of Neurological Surgery, Oregon Health and Science University, Portland, Oregon 97239 Regulator of G-protein signaling (RGS) proteins classically function as negative modulators of G-protein-coupled receptor signaling. In vitro, RGS proteins have been shown to inhibit signaling by agonists at the ␮-opioid receptor, including morphine. The goal of the present study was to evaluate the contribution of endogenous RGS proteins to the antinociceptive effects of morphine and other opioid agonists. ␣ ␣ G184S ␣ To do this, a knock-in mouse that expresses an RGS-insensitive (RGSi) mutant G o protein, G o (G o RGSi), was evaluated for ␣ morphine or methadone antinociception in response to noxious thermal stimuli. Mice expressing G o RGSi subunits exhibited a naltrexone-sensitive enhancement of baseline latency in both the hot-plate and warm-water tail-withdrawal tests. In the hot-plate test, a measureofsupraspinalnociception,morphineantinociceptionwasincreased,andthiswasassociatedwithanincreasedabilityofopioids to inhibit presynaptic GABA neurotransmission in the periaqueductal gray. In contrast, antinociception produced by either morphine or methadone was reduced in the tail-withdrawal test, a measure of spinal nociception. In whole-brain and spinal cord homogenates from ␣ ␣ mice expressing G o RGSi subunits, there was a small loss of G o expression and an accompanying decrease in basal G-protein activity.
    [Show full text]
  • FY2006 Society for Neuroscience Annual Report
    Navigating A Changing Landscape FY2006 Annual Report 2005–2006 Society for 2005–2006 Society Past Presidents Neuroscience Council for Neuroscience Committee Chairs Carol A. Barnes, PhD, 2004–05 OFFICERS Anne B. Young, MD, PhD, 2003–04 Stephen F. Heinemann, PhD Darwin K. Berg, PhD Huda Akil, PhD, 2002–03 President Audit Committee Fred H. Gage, PhD, 2001–02 David Van Essen, PhD John H. Morrison, PhD Donald L. Price, MD, 2000–01 President-Elect Committee on Animals in Research Dennis W. Choi, MD, PhD, 1999–00 Carol A. Barnes, PhD Irwin B. Levitan, PhD Edward G. Jones, MD, DPhil, 1998–99 Past President Committee on Committees Lorne M. Mendell, PhD, 1997–98 Bruce S. McEwen, PhD, 1996–97 Michael E. Goldberg, MD William J. Martin, PhD Treasurer Committee on Diversity in Neuroscience Pasko Rakic, MD, PhD, 1995–96 Carla J. Shatz, PhD, 1994–95 Christine M. Gall, PhD Rita J. Balice-Gordon, PhD Larry R. Squire, PhD, 1993–94 Treasurer-Elect Judy Illes, PhD (Co-chairs) Committee on Women in Neuroscience Ira B. Black, MD, 1992–93 William T. Greenough, PhD Joseph T. Coyle, MD, 1991–92 Past Treasurer Michael E. Goldberg, MD Robert H. Wurtz, PhD, 1990–91 Finance Committee Irwin B. Levitan, PhD Patricia S. Goldman-Rakic, PhD, 1989–90 Secretary Mahlon R. DeLong, MD David H. Hubel, MD, 1988–89 Government and Public Affairs Committee Albert J. Aguayo, MD, 1987–88 COUNCILORS Darwin K. Berg, PhD Laurence Abbott, PhD Mortimer Mishkin, PhD, 1986–87 Information Technology Committee Bernice Grafstein, PhD, 1985–86 Joanne E. Berger-Sweeney, PhD William D.
    [Show full text]
  • Art Meets Science in “The Beautiful Brain” “One of the Most Unusual, Ravishing Exhibitions of the Season.”— the New York Times
    Art Meets Science in “The Beautiful Brain” “One of the most unusual, ravishing exhibitions of the season.”— The New York Times FOR IMMEDIATE RELEASE Chapel Hill, N.C. — Jan. 4, 2019 The Ackland Art Museum at the University of North Carolina at Chapel Hill presents the new exhibition “The Beautiful Brain: The Drawings of Santiago Ramón y Cajal,” on view from Friday, Jan. 25 through Sunday, April 7, 2019. Santiago Ramón y Cajal’s drawings of the brain are both aesthetically astonishing and scientifically significant, and “The Beautiful Brain” is the first museum exhibition to present these extraordinary works in their historical context. Cajal, (1852-1934), was an artist from rural Spain who became the Nobel Prize-winning father of modern neuroscience. He made the pathbreaking discovery that the brain is composed of individual neurons that communicate across minute gaps, or synapses. Cajal saw the brain with an artist’s eye; his drawings of the microanatomy of the brain have never been equaled in clarity or beauty, and they continue to be used as teaching tools to this day. As important to neurology as Einstein is to the study of physics, Cajal upends the prevalent cultural assumption that art and science are always and entirely separate. Katie Ziglar, director of the Ackland, said of “The Beautiful Brain,” “This exhibition is an exceptional opportunity for cross-disciplinary collaboration between the Ackland Art Museum and the UNC Neuroscience Center. The Ackland will exhibit images made by UNC-Chapel Hill neuroscientists alongside Cajal’s iconic drawings, and we’ll host an ongoing dialogue between Museum curators and UNC-Chapel Hill scientists.
    [Show full text]
  • CHAPTER ONE 1.0 INTRODUCTION for Centuries, Plants Have Provided
    CHAPTER ONE 1.0 INTRODUCTION For centuries, plants have provided man with an array of products crucial to social-economic life. Medicinal plants in particular have been highly valued and used regularly for thousands of years by the people of the world as the medicine of the masses. Man has always searched for that herb that heals the body and soothes the mind and there has never been a shortage of vegetation to investigate with some 20,000 species that have been used by various cultures. Medicinal plants have been used to treat psychiatric and behavioral conditions such as anxiety, depression, seizures, dementia and insomnia (Klemens, 2006). However, as western medicine evolved through the twentieth century, people wanted to swallow pill of a concentrated "active ingredient," or, perhaps a synthetic pharmaceutical equivalent. As a result, potentially valuable herbal formulation may not have been investigated and are forever lost owing to a dramatic substitution of herbs for orthodox drugs. The stigma attached to substance use and abuse also contributes to insufficient documentation and scientific investigation of African psychotropic plants, thus resulting to low priority ascribed to medicinal plants and hence silence and loss of research interest in psychoactive plants (Carlini, 2003). Carlini (2003) reported that “most psychoactive plants first used by the so-called primitive cultures were relegated by European occidental culture to a second plan and considered them as sorcerer’s therapeutics and often viewed in a negative light”. This impression has led to the abandonment of the endowment of nature for therapeutic remedies. Although current drugs used for the treatment of these disorders have gained popularity among the users, there is still a serious and growing concern on their therapeutic effectiveness.
    [Show full text]
  • Long-Term Potentiation of Glycinergic Synapses Triggered by Interleukin 1Β
    Long-term potentiation of glycinergic synapses triggered by interleukin 1β Anda M. Chirila1, Travis E. Brown1,2, Rachel A. Bishop, Nicholas W. Bellono, Francesco G. Pucci, and Julie A. Kauer3 Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI 02912 Edited* by Gina G. Turrigiano, Brandeis University, Waltham, MA, and approved April 18, 2014 (received for review January 17, 2014) Long-term potentiation (LTP) is a persistent increase in synaptic become apparent only when GABAAR and GlyRs are pharma- strength required for many behavioral adaptations, including learn- cologically blocked, indicating that under conditions of disinhibi- ing and memory, visual and somatosensory system functional devel- tion, nonnoxious mechanical stimuli can drive nociceptive-specific opment, and drug addiction. Recent work has suggested a role for projection pathways and elicit allodynia (21). The majority of LTP-like phenomena in the processing of nociceptive information in neurons tested in the dorsal horn receive glycinergic synapses, in- the dorsal horn and in the generation of central sensitization during cluding lamina I projection neurons, both excitatory and inhibitory chronic pain states. Whereas LTP of glutamatergic and GABAergic interneurons of lamina II (22, 23), and inhibitory glycinergic neurons synapses has been characterized throughout the central nervous (24). Given the diversity of afferent targets, it is likely that glycinergic system, to our knowledge there have been no reports of LTP at mam- synapses are differentially modulated in a cell type- and subregion- malian glycinergic synapses. Glycine receptors (GlyRs) are structurally specific manner. For example, during chronic inflammation, pros- related to GABAA receptors and have a similar inhibitory role.
    [Show full text]
  • A Role for ASIC3 in the Modulation of High-Intensity Pain Stimuli
    A role for ASIC3 in the modulation of high-intensity pain stimuli Chih-Cheng Chen*, Anne Zimmer*†, Wei-Hsin Sun*, Jennifer Hall*, Michael J. Brownstein*, and Andreas Zimmer*†‡ *Laboratory of Genetics, National Institute of Mental Health, 36 Convent Drive 3D06, Bethesda, MD 20892; and †Laboratory of Molecular Neurobiology, Department of Psychiatry, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany Communicated by Jean-Pierre Changeux, Institute Pasteur, France, April 24, 2002 (received for review February 18, 2002) Acid-sensing ion channel 3 (ASIC3), a proton-gated ion channel of neurons such as a reduced sensitivity of some mechanoreceptors the degenerins͞epithelial sodium channel (DEG͞ENaC) receptor to noxious pinch and an enhanced sensitivity to light touch (6). family is expressed predominantly in sensory neurons including However, the contribution of ASIC3 to pain signaling remains nociceptive neurons responding to protons. To study the role of unclear. In this study we show that ASIC3Ϫ͞Ϫ animals display ASIC3 in pain signaling, we generated ASIC3 knockout mice. enhanced behavioral responses to high-intensity nociceptive Mutant animals were healthy and responded normally to most stimuli regardless of their modality. These results reveal a role sensory stimuli. However, in behavioral assays for pain responses, for ASIC3 in the tonic inhibition of high-intensity pain signals. ASIC3 null mutant mice displayed a reduced latency to the onset of pain responses, or more pain-related behaviors, when stimuli of Materials and Methods -moderate to high intensity were used. This unexpected effect Generation and Breeding of ASIC3؊͞؊ Mice. Genomic clones con seemed independent of the modality of the stimulus and was taining the mouse ASIC3 gene were screened from a 129͞Sv observed in the acetic acid-induced writhing test (0.6 vs.
    [Show full text]
  • Neurophysiology of Pain : Insight to Orofacial Pain
    Indian J Physiol Pharmacol 2003; 47 (3) : 247–269 REVIEW ARTICLE NEUROPHYSIOLOGY OF PAIN : INSIGHT TO OROFACIAL PAIN O. P. TANDON*†, V. MALHOTRA*, S. TANDON** AND I. D’SILVA *Department of Physiology, University College of Medical Sciences & Guru Teg Bahadur Hospital, Dilshad Garden, Delhi – 110 095 and **Department of Periodontia, Nair Hospital Dental College, Mumbai – 400 008 ( Received on January 22, 2003 ) Abstract : This is a very exciting time in the field of pain research. Major advances are made at every level of analysis from development to neural plasticity in the adult and from the transduction of a noxious stimulus in a primary afferent neuron to the impact of this stimulus on cortical circuitry. The molecular identity of nociceptors, their stimulus transduction processes and the ion channels involved in the generation, modulation and propagation of action potentials along the axons in which these nociceptors are present are being vigorously perused. Similarly tremendous progress has occurred in the identification of the receptors, transmitters, second messenger systems, transcription factors, and signaling molecules underlying the neural plasticity observed in the spinal cord and brainstem after tissue or nerve injury. With recent insight into the pharmacology of different neural circuits, the importance of descending modulatory systems in the response of the nervous system to persistent pain after injury is being reevaluated. Finally, imaging studies revealed that information about tissue damage is distributed at multiple forebrain sites involved in attentional, motivational, and cognitive aspects of the pain experience. Key words : pain pathways evaluation pain relief orofacial pain evoked potentials TSEPs INTRODUCTION Association for the study of pain has defined pain as an unpleasant sensory and emotional Pain : the International perspective experience associated with actual or potential tissue damage (1).
    [Show full text]